Anebulo Pharmaceuticals I...

NASDAQ: ANEB · Real-Time Price · USD
2.51
0.07 (2.87%)
At close: Aug 15, 2025, 3:59 PM
2.50
-0.40%
After-hours: Aug 15, 2025, 04:10 PM EDT

Anebulo Pharmaceuticals Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-8.31M -11.78M -6.83M -3.61M
Interest Income
249.02K 92.41K 7.33K 1.02K
Pretax Income
-8.2M -11.73M -6.83M -30.25M
Net Income
-8.2M -11.73M -6.83M -30.25M
Selling & General & Admin
4.76M 6.18M 3.87M 1.34M
Research & Development
3.55M 5.6M 2.96M 2.27M
Other Expenses
n/a -41.15K -1.78K -1.34K
Operating Expenses
8.31M 11.78M 6.83M 3.61M
Interest Expense
151.23K n/a 7.33K 11.77K
Selling & Marketing Expenses
4.8K n/a n/a n/a
Cost & Expenses
8.31M 11.78M 6.83M 3.61M
Income Tax Expense
n/a -104K -12.89K 10.75K
Shares Outstanding (Basic)
25.82M 25.07M 23.34M 23.34M
Shares Outstanding (Diluted)
25.82M 25.07M 23.34M 23.34M
EPS (Basic)
-0.32 -0.47 -0.29 -1.3
EPS (Diluted)
-0.32 -0.47 -0.29 -1.3
EBITDA
-8.05M -11.78M 5.55K -30.24M
EBIT
-8.05M -11.73M -6.83M -30.24M
Depreciation & Amortization
258.28K 11.78M 6.83M n/a